Tag: ACADIA Pharmaceuticals

May 28, 2019

8 Small Biotech ETFs

Want to invest in small biotech ETFs? Here we profile eight that life science investors may want to look into.
October 31, 2018

ACADIA Pharmaceuticals Announces Positive Top-line Results from Phase 2 CLARITY Trial

ACADIA Pharmaceuticals (Nasdaq:ACAD) today announced positive top-line results from CLARITY, a randomized, double-blind, placebo-controlled, multi-center, sequential parallel comparison design (SPCD)...
August 7, 2018

ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Exclusive License Agreement

ACADIA Pharmaceuticals (NASDAQ:ACAD) and Neuren Pharmaceuticals (ASX:NEU) announced today that they have entered into an exclusive North American License Agreement...
July 10, 2018

Pharmaceutical Update: Q2 2018 in Review

With Q2 officially behind us and Q3 already in full swing, here the Investing News Network is providing a look...
June 29, 2018

ACADIA Pharmaceuticals Announces FDA Approval of New Dosing Formulation and Strength for NUPLAZID (Pimavanserin)

ACADIA Pharmaceuticals (Nasdaq:ACAD) today announced FDA approval of a new capsule dose formulation and a new tablet strength of NUPLAZID...
February 19, 2018

5 Top Performing Life Science ETFs

Who are the top performing ETFs in the pharmaceuticals, biotechnology and life sciences markets year-to-date?
November 15, 2016

ACADIA Pharmaceuticals Initiates Phase II Trial of Pimavanserin for Adjunctive Treatment in Patients

ACADIA Pharmaceuticals, a biopharmaceutical company focused on innovative treatments that address unmet medical needs in central nervous system disorders, today...